Foreign-Trade Zone (FTZ) 224; Authorization of Production Activity; Jubilant HollisterStier, LLC; (Pharmaceuticals); Spokane, Washington
---
identifier: "/us/fr/2024-17904"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Foreign-Trade Zone (FTZ) 224; Authorization of Production Activity; Jubilant HollisterStier, LLC; (Pharmaceuticals); Spokane, Washington"
title_number: 0
title_name: "Federal Register"
section_number: "2024-17904"
section_name: "Foreign-Trade Zone (FTZ) 224; Authorization of Production Activity; Jubilant HollisterStier, LLC; (Pharmaceuticals); Spokane, Washington"
positive_law: false
currency: "2024-08-12"
last_updated: "2024-08-12"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Commerce Department"
document_number: "2024-17904"
document_type: "notice"
publication_date: "2024-08-12"
agencies:
- "Commerce Department"
- "Foreign-Trade Zones Board"
fr_citation: "89 FR 65583"
fr_volume: 89
docket_ids:
- "B-15-2024"
---
# Foreign-Trade Zone (FTZ) 224; Authorization of Production Activity; Jubilant HollisterStier, LLC; (Pharmaceuticals); Spokane, Washington
On April 9, 2024, Jubilant HollisterStier, LLC, submitted a notification of proposed production activity to the FTZ Board for its facility within Subzone 224A, in Spokane, Washington.
The notification was processed in accordance with the regulations of the FTZ Board (15 CFR part 400), including notice in the *Federal Register* inviting public comment (89 FR 26125, April 15, 2024). On August 7, 2024, the applicant was notified of the FTZ Board's decision that no further review of the activity is warranted at this time. The production activity described in the notification was authorized, subject to the FTZ Act and the FTZ Board's regulations, including section 400.14.
Dated: August 7, 2024.
Camille R. Evans,
Acting Executive Secretary.